340binformed.org

Your Free Source for 340B News and Commentary

  • About us
  • Advertise
  • Contact
  • 340B Health

Hospital Survey: Genentech’s Cancer Drug Distribution Change Raises Costs, Disrupts Care

Move to specialty channel also raises risk of 340B noncompliance, hospitals warn 

March 6, 2015—Genentech's decision last fall to move its top-selling cancer drugs Avastin, Herceptin, and Rituxan into the specialty distribution channel has cost hospitals more than $300 million and disrupted patient care, a survey of more than 200 hospitals has found. Nearly two out of five hospitals (39 percent) surveyed said the change affects their risk of 340B program … [Read more...]

MedPAC: No 340B Recommendations to Congress This Year

June report will include a chapter about 340B, but it won't suggest any changes 

March 6, 2015—The Medicare Payment Advisory Commission will include a chapter about the 340B program in its June report to Congress, Chairman Glenn Hackbarth said during yesterday's commission meeting. But it will make no recommendations about 340B at this time, he added, and it remains up in the air whether the commission will make such recommendations at all. … [Read more...]

HRSA Has Sharpened 340B Oversight, Agencies Tell House Panel

Written testimony posted in advance of hearing, which has been postponed 

March 4, 2015—The Health Resources and Services Administration has significantly strengthened its oversight of the 340B program in recent years, government witnesses say in written testimony submitted in advance of a congressional hearing on the drug discount program. … [Read more...]

Hospital Outpatient Departments Treat Sicker, Poorer Patients, Study Finds

Research released amid debate over site-neutral payments 

March 4, 2015—Patients receiving care in hospital outpatient departments are sicker and poorer than those receiving care in physician offices and could lose access to care if Congress significantly reduces payments to outpatient departments, a new study has found.      … [Read more...]

House Appropriations Chairman Questions 340B User Fee

Levy will "wreak havoc" in rural areas, Rep. Rogers says 

March 4, 2015—The Obama administration's proposed 0.1 percent user fee on 340B drug purchases "will wreak havoc on healthcare providers, especially those in rural areas," the chairman of the House Appropriations Committee has told the Secretary of Health and Human Services. … [Read more...]

PhRMA Says HRSA Misinterprets 340B Orphan Drug Exclusion

Asks court to declare interpretive rule invalid 

February 26, 2015—The Department of Health and Human Services Health Resources and Services Administration cannot second-guess Congress and rewrite the 340B orphan drug exclusion "to make the statute correspond with the agency's policy preference," brand-name drugmakers said yesterday in a court filing. … [Read more...]

House Subcommittee Holding 340B Hearing Next Week

Will hear from government witnesses on March 5 

February 25, 2015—The House Energy & Commerce Health Subcommittee has scheduled a hearing on the 340B program for March 5 at 10:00 a.m. … [Read more...]

« Previous Page
Next Page »

LATEST ARTICLES DELIVERED

Get new article alerts via email.

This field is required.

Check your inbox or spam folder now to confirm your subscription.

FOLLOW | SHARE | LIKE

  • Facebook
  • LinkedIn
  • Twitter
  • YouTube

340B Health Twitter

Twitter feed is not available at the moment.

RSS feed: 340B Employed 340B Employed

  • 340B Program Compliance Analyst Certified | UNC Health November 17, 2026
  • 340B Program Compliance Analyst Certified | UNC Health November 17, 2026
  • 340B Program Specialist | Vail Health November 17, 2026
  • Pharmacy Manager, 340B Program | Tufts Medical Center November 11, 2026
  • 340B Program Pharmacy Manager | Allies for Health + Wellbeing November 10, 2026

Copyright © 2026 · 340B Health